Cargando…
Evaluation of OspA Vaccination-Induced Serological Correlates of Protection against Lyme Borreliosis in a Mouse Model
BACKGROUND: For clinical development of a novel multivalent OspA vaccine against Lyme borreliosis, serological assays are required which can be used to establish immune correlates of protection against infection with Borrelia. METHODS: Four assays (an OspA IgG ELISA, a competitive inhibition (CI) EL...
Autores principales: | Schwendinger, Michael G., O'Rourke, Maria, Traweger, Andreas, Savidis-Dacho, Helga, Pilz, Andreas, Portsmouth, Daniel, Livey, Ian, Barrett, P. Noel, Crowe, Brian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832494/ https://www.ncbi.nlm.nih.gov/pubmed/24260146 http://dx.doi.org/10.1371/journal.pone.0079022 |
Ejemplares similares
-
The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes
por: Comstedt, Pär, et al.
Publicado: (2017) -
The year that shaped the outcome of the OspA vaccine for human Lyme disease
por: Dattwyler, Raymond J., et al.
Publicado: (2022) -
Essential Role for OspA/B in the Life Cycle of the Lyme Disease Spirochete
por: Yang, Xiaofeng F., et al.
Publicado: (2004) -
Borrelia burgdorferi OspA is an arthropod-specific transmission- blocking Lyme disease vaccine
Publicado: (1996) -
MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
por: Hessel, Annett, et al.
Publicado: (2014)